Selected article for: "accurate monitoring and acute respiratory"

Author: Wang, Yueying; Wang, Zhaojia; Tse, Gary; Zhang, Lin; Wan, Elaine Y.; Guo, Yutao; Lip, Gregory Y. H.; Li, Guangping; Lu, Zhibing; Liu, Tong
Title: Cardiac arrhythmias in patients with COVID‐19
  • Cord-id: s8bm40vy
  • Document date: 2020_7_26
  • ID: s8bm40vy
    Snippet: The emergence of coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a major global public health concern. Although SARS‐CoV‐2 causes primarily respiratory problems, concurrent cardiac injury cannot be ignored since it may be an independent predictor for adverse outcomes. Cardiac arrhythmias are often observed in patients with COVID‐19, especially in severe cases, and more likely contribute to the high risk of adv
    Document: The emergence of coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a major global public health concern. Although SARS‐CoV‐2 causes primarily respiratory problems, concurrent cardiac injury cannot be ignored since it may be an independent predictor for adverse outcomes. Cardiac arrhythmias are often observed in patients with COVID‐19, especially in severe cases, and more likely contribute to the high risk of adverse outcomes. Arrhythmias should be regarded as one of the main complications of COVID‐19. Mechanistically, a number of ion channels can be adversely affected in COVID‐19, leading to alterations in cardiac conduction and/or repolarization properties, as well as calcium handling, which can predispose to cardiac arrhythmogenesis. In addition, several antimicrobials that are currently used as potential therapeutic agents for COVID‐19, such as chloroquine, hydroxychloroquine and azithromycin, have uncertain benefit, and yet may induce electrocardiographic QT prolongation with potential ventricular pro‐arrhythmic effects. Continuous electrocardiogram monitoring, accurate and prompt recognition of arrhythmias are important. The present review focuses on cardiac arrhythmias in patients with COVID‐19, its underlying mechanisms, and proposed preventive and therapeutic strategies.

    Search related documents:
    Co phrase search for related documents
    • acute cardiac injury and admission require: 1
    • acute cardiac injury and lopinavir ritonavir: 1, 2, 3, 4
    • acute coronary syndrome and admission require: 1
    • acute coronary syndrome and lopinavir ritonavir: 1, 2
    • acute heart failure and admission heart rate: 1
    • acute heart failure and admission require: 1
    • acute heart failure and lopinavir ritonavir: 1
    • acute myocardial infarction and lopinavir ritonavir: 1
    • acute sars cov respiratory syndrome coronavirus and admission heart rate: 1
    • acute sars cov respiratory syndrome coronavirus and admission require: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir azithromycin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute shock respiratory distress syndrome and admission require: 1, 2, 3, 4, 5, 6, 7
    • acute shock respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3
    • admission require and lopinavir ritonavir: 1, 2
    • admission require and lopinavir ritonavir azithromycin: 1
    Co phrase search for related documents, hyperlinks ordered by date